|
市場調査レポート
商品コード
1408301
HIFU (高密度焦点式超音波) の世界市場:規模、予測 (2024~2030年)、産業動向、 シェア、成長、考察、インフレーションの影響、企業の分析High Intensity Focused Ultrasound (HIFU) Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis |
||||||
HIFU (高密度焦点式超音波) の世界市場:規模、予測 (2024~2030年)、産業動向、 シェア、成長、考察、インフレーションの影響、企業の分析 |
出版日: 2024年01月01日
発行: Renub Research
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
|
世界のHIFU (高密度焦点式超音波) 治療の市場は、2030年までに約1億9,418万米ドル規模になると予測されています。HIFUは特定の超音波を利用して特定の組織を狙い撃ちし、周囲にダメージを与えることなく治療用の熱を発生させます。前立腺がんや子宮筋腫のような状況に広く使用されているHIFUは、標準的な薬と比較して、治癒のインスタンスと副作用を最小限に抑えることができます。HIFUの評判は、その精密さ、低侵襲性、さまざまな医療分野での能力プログラムから生じています。非外科的介入に対する需要が高まるにつれ、HIFUは、その有効性と患者への最小限の影響により、臨床パノラマ内の進歩を利用した変革的技術として浮上しています。
がん罹患率は発展途上国に不釣り合いなほど高く、世界疾病負担率 (GBD) によると、生涯を通じて約3人に1人が罹患しています。子宮筋腫は、50歳の女性の77%が罹患し、2億2,605万件の症例が予想され、世界の医療需要の課題に顕著に寄与しています。高齢者人口の増加と慢性疾患の急増は、世界の医療費を急拡大させています。HIFUは、医療企業や支払者にとって魅力的な対応策であり、費用対効果と低侵襲の介入を提供します。HIFUの利点に対する認識の高まりは、科学的証明の積み重ねに支えられて、患者や医療専門家の間で需要の増加を促し、HIFU治療市場の増加を推進しています。
さらに、HIFUは臨床革新の最前線に立っており、疾患治療戦術を変革する態勢を整えています。高周波音波で特定の組織に正確に集中するHIFUは、従来の手術や放射線治療に低侵襲で定期的な治癒の機会を提供します。技術的な進歩がこの分野の成長を後押しし、リアルタイムの画像処理の改善、標的精度を向上させるロボット構造、より深い組織浸透を可能にする最新のトランスデューサー設計を提供しています。先進的なソフトウェア・プログラムが治療計画を支援する一方、人工知能 (AI) はカスタマイズされた最適化を探求しています。HIFUはがん以外にも拡大し、発展途上の臨床エビデンスに支えられた多様な用途で有望視されています。新たな動向には、クローズドループ構造、併用療法、ガジェットの小型化の可能性などがあり、HIFUは、高度な患者ケアと結果のための継続的な興味深い技術革新を伴う主流の代替治療として位置づけられています。したがって、HIFU治療市場は2023年に1億1,555万米ドルと評価されました。
HIFU治療市場を技術別に見ると、革新的技術であるMRI HIFU治療が、MRIステアリングをHIFUプロセスにシームレスに統合し、世界のHIFU市場の大幅な増加を牽引しています。研究によると、MRI HIFUは、特に複雑な症例において成功率が高く、頭痛が少ないことが示されており、その低侵襲性は保たれ、回復時間と入院率が低下しています。その精度の高さは、前立腺がん、肝腫瘍、子宮筋腫、重篤な震えなど、数多くの症状への応用を広げています。
用途別に見ると、世界で最も一般的ながんである前立腺がんが、その低侵襲技術、初期レベルの症例における実証された有効性、より早い治癒のための非外科的利点により、HIFUの需要を牽引しています。HIFUの非外科的利点は、より迅速な治癒と最小限の出血であり、最小侵襲の選択肢を求める人々にアピールします。予備的治療、救済治療、緩和治療におけるその汎用性は、その有用性を広げています。特にリアルタイムの画像処理とエネルギー供給における技術改良は、精度、有効性、安全性を高め、HIFUの競争力を確実に維持します。患者や医療専門家の間での注目の高まりが市場の需要を促進し、HIFUの可能性を見いだし新たな応用を承認する支持的な規制環境が拡大を推進し技術革新を促進します。
エンドユーザー別に見ると、病院ではHIFUを泌尿器科、腫瘍科、疼痛コントロールなどの医療専門分野にシームレスに組み合わせ、専用の治療施設、訓練を受けた従業員、優れた画像処理、頑丈なインフラを保有しています。病院は紹介センターとして患者をHIFU治療に導き、虜にする患者を作り出します。病院の金銭的資産は、HIFU装置へのフルサイズの投資を可能にし、一貫したアクセスを保証しています。主要な病院はHIFU研究に積極的に貢献し、技術革新を促進し、治療プロトコルを改善しています。また、規制遵守、保護プロトコル、報酬交渉における役割は、世界のHIFU市場の舵取りにおける優位性を確固たるものにしています。
国別に見ると、米国では、初期の貢献と現在進行中の改良がメーカーを強化し、FDAの堅固な規制枠組みが自己肯定感を植え付け、医療システムにおけるHIFUの普及を促進します。米国の高い医療率が、病院による最新技術の迅速な導入を促進します。政府の重要な研究と改善されたインフラは、HIFUの技術革新を促進し、投資と人材を惹きつけています。
当レポートでは、世界のHIFU (高密度焦点式超音波) の市場について分析し、市場の基本構造や主な市場促進・抑制要因、全体的な市場規模の動向見通し、セグメント別・地域別の詳細動向、主要企業のプロファイルと業績動向などを調査しております。
High-intensity targeted ultrasound therapy market is anticipated to be worth around US$ 194.18 Million by 2030, as according to Renub Research. High-Intensity Focused Ultrasound (HIFU) therapy is a modern-day scientific approach gaining prominence for its non-invasive method. HIFU objectives specific tissues with the aid of using particular ultrasound waves, generating heat for therapeutic applications without damaging surrounding areas. Widely used for situations like prostate cancer and uterine fibroids, HIFU minimizes healing instances and side effects compared to standard medications. Its reputation stems from its precision, decreased invasiveness, and capability programs in various medical fields. As demand for non-surgical interventions rises, HIFU emerges as a transformative technology, using advancements within the clinical panorama with its effectiveness and minimum impact on patients.
Cancer rates are disproportionately excessive in developing nations, affecting about One in Three people all through their lifetime, as per the Global Burden of Diseases (GBD). Uterine fibroids, 77% of ladies of age 50, contribute notably to global healthcare demanding challenges, with an expected 226.05 Million cases. The growing elderly populace and the surge in chronic diseases are escalating global healthcare expenditure. High-Intensity Focused Ultrasound (HIFU) is an attractive response for healthcare companies and payers, offering cost effectiveness and minimally invasive interventions. The increasing cognizance of HIFU's benefits, supported by mounting scientific proof, drives increasing demand among patients and healthcare professionals, propelling the HIFU therapy market increase.
Further, High-depth, focused ultrasound stands at the forefront of clinical innovation, poised to transform disease treatment tactics. Precisely concentrating on particular tissues with high-frequency sound waves, HIFU provides a minimally invasive and regularly curative opportunity to conventional surgery and radiation therapy. Technological strides propel the sector's increase, providing real-time imaging improvements, robot structures improving targeting accuracy, and modern transducer designs allowing deeper tissue penetration. Advanced software programs aid treatment planning, while A.I. explores customized optimization. Expanding beyond cancer, HIFU shows promise in diverse applications sponsored by developing clinical evidence. Emerging trends include closed-loop structures, combination therapies, and the potential miniaturization of gadgets, positioning HIFU as a mainstream healing alternative with ongoing interesting innovations for advanced patient care and results. Hence, the High-Intensity Focused Ultrasound Therapy Market was valued at US$ 115.55 Million in 2023.
Besides, regulatory approvals are pivotal for HIFU technology, boosting credibility and spurring investor confidence, prompting improved investment in research, improvement, and commercialization. Beyond confidence-building, approvals broaden HIFU's market reach by endorsing new applications, tapping into untapped patient populations, diversifying treatments, and adding revenue streams. Examples encompass U.S. Food and Drug Administration (FDA) approvals for chronic tremor, prostate cancer, uterine fibroids, and persistent pain, European Medicines Agency (EMA) acclaim for uterine fibroids, and Chinese Food and Drug Administration (CFDA) approval for liver cancer, pancreatic cancer, and bone tumors. The HIFU market's expansion into aesthetic applications, like skin tightening and fat removal, similarly propels usual growth.
The high-intensity focused ultrasound therapy market is divided into ultrasound HIFU therapy and MRI HIFU therapy by imaging technology. This innovative technique seamlessly integrates MRI steering into the HIFU process, driving a sizeable increase in the global HIFU market. Studies indicate advanced success rates and lower headaches for MRI HIFU, especially in complicated cases, preserving its minimally invasive nature and lowering restoration times and hospitalization rates. Its precision expands applications across numerous conditions like prostate cancer, liver tumors, uterine fibroids, and critical tremors.
Continuous technological improvements in MRI and HIFU transducers shape the market's trajectory, enhancing accuracy and efficacy. Mounting clinical evidence supports the protection and effectiveness of MRI HIFU, fostering wider adoption by healthcare providers. Increased focus has precipitated heightened funding, contributing to the ongoing growth and promising future outlook of the MRI HIFU market.
By application, the High-Intensity Focused Ultrasound Therapy Market is fragmented into Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others. Prostate cancer, the most common cancer globally, drives the demand for HIFU (high-depth focused ultrasound) due to its minimally invasive technique, proven efficacy in early-level cases, and non-surgical benefits for faster healing. HIFU's non-surgical benefits, which include more rapid healing and minimal blood loss, appeal to those seeking minimum invasive options. Its versatility in preliminary remedy, salvage therapy, and palliation widens its utility. Technological improvements, especially in real-time imaging and energy delivery, enhance accuracy, efficacy, and safety, ensuring HIFU stays competitive. Increasing attention amongst patients and healthcare professionals drives market demand, while a supportive regulatory environment, spotting HIFU's potential and approving new applications, propels expansion and fosters innovation.
By end-user, the High-Intensity Focused Ultrasound Therapy Market is broken up into Diagnostic Centers, Hospitals, Research Centers, and Others. Hospitals seamlessly combine HIFU into their medical specialties, consisting of urology, oncology, and pain control, possessing dedicated remedy facilities, trained employees, superior imaging, and sturdy infrastructure. Hospitals channel patients to HIFU remedies as referral centers, creating a captive audience. Their monetary assets permit full-size investments in HIFU devices, ensuring consistent access. Leading hospitals actively contribute to HIFU research, fostering innovation and improving therapy protocols. Also, their regulatory compliance, protection protocols, and role in compensation negotiations solidify their dominance in steering the global HIFU market.
By country, the High-Intensity Focused Ultrasound Therapy Market is categorized into United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa and Rest of World. Early contributions and ongoing improvements bolster U.S. producers, with the FDA's sturdy regulatory framework instilling self-assurance and promoting widespread HIFU adoption in the healthcare system. High U.S. healthcare rates facilitate the speedy adoption of modern-day technologies by hospitals. The state's vital research and improved infrastructure drives HIFU innovation, attracting investment and talent.
Aligned with the healthcare system's preference for minimally invasive methods, HIFU's non-surgical technique fits situations like prostate cancer and uterine fibroids. Growing public focus, fuelled by media and advocacy, propels HIFU demand, encouraging healthcare companies to combine it prominently. The favorable repayment panorama incentivizes hospitals and vendors to embody HIFU readily.
Koninklijke Philips N.V., Johnson & Johnson, Hitachi Ltd., General Electrics, Medtronic Plc., Stryker, EDAP TMS S.A, and Theraclion are prominent players in the High Intensity Focused Ultrasound Therapy Market.
Renub Research report titled "High Intensity Focused Ultrasound Therapy Market Forecast by imaging technology (Ultrasound HIFU Therapy, and MRI HIFU Therapy), application (Prostate Cancer, Uterine Fibroids, Neurological Disorders, Aesthetics, and Others), end-user (Diagnostic Centers, Hospitals, Research Centers, and Others), country (United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa, and Rest of the World), company (Koninklijke Philips N.V., Johnson & Johnson, Hitachi Ltd., General Electrics, Medtronic Plc., Stryker, EDAP TMS S.A, and Theraclion)" provides a detailed and comprehensive insight of the High Intensity Focused Ultrasound Therapy Industry.